Rebecca Valentin, MD, PhD

Genmab, Denmark

Poster(s):

• 1606 - Epcoritamab Monotherapy in Patients with First-Line Richter’s Transformation: 2-Year Follow-Up Results From the Phase 1b/2 EPCORE CLL-1 Clinical Trial